Back to Results
First PageMeta Content
Organochlorides / Antiprotozoal agents / Guanidines / Atovaquone/proguanil / Proguanil / Atovaquone / Medical prescription / Antimalarial medication / Prescription medication / Medicine / Pharmacology / Chemistry


Microsoft Word - Malarone BPCA D030493 for AC Background Packet.doc
Add to Reading List

Document Date: 2005-02-11 16:13:39

Open Document

File Size: 171,10 KB

Share Result on Facebook

Company

IMS Health / MD SPECIALTY / /

Country

United States / /

IndustryTerm

hydoxychloroquine accounting / retail pharmacies / pharmaceuticals / non-retail channels / retail / fixed combination products / Treatment of Malaria / food store / insurance plans / ingredient products / retail dispensing / /

MedicalCondition

Malaria / outpatient drug usage / P. falciparum malaria / infectious disease / /

Organization

Congress / MPH Epidemiologist Division of Surveillance / Research and Communication Support / FOOD AND DRUG ADMINISTRATION / HFD-960 office of Counter-Terrorism / Pharmacist/Drug Use Specialist Division of Surveillance / Research and Communication Support / Pediatric Exclusivity Board / Anti-Infective Drugs Advisory Committee / Pediatric Advisory Subcommittee / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Division of Surveillance / Research and Communication Support / /

Person

Michael C. Evans / Solomon Iyasu / Gerald Dal / Dal Pan / /

Position

prescribing physician / pharmacy benefit manager / Director / Manager Database / EXECUTIVE / representative / /

Product

PUBLIC HEALTH SERVICE FOOD AND DRUG / National Prescription Audit Plus™ / Malarone Pediatric / Mefloquine / Primaquine / RESULTS I. Dispensed Prescriptions Dispensed prescriptions / Nationwide Prescriptions / Malarone / measured using IMS Health’s National Prescription Audit Plus™ / /

ProvinceOrState

Maryland / /

SocialTag